BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22345057)

  • 1. Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.
    Boedeker E; Friedel G; Walles T
    Interact Cardiovasc Thorac Surg; 2012 May; 14(5):511-5. PubMed ID: 22345057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sniffer dogs can identify lung cancer patients from breath and urine samples.
    Feil C; Staib F; Berger MR; Stein T; Schmidtmann I; Forster A; Schimanski CC
    BMC Cancer; 2021 Aug; 21(1):917. PubMed ID: 34388977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon.
    Ehmann R; Boedeker E; Friedrich U; Sagert J; Dippon J; Friedel G; Walles T
    Eur Respir J; 2012 Mar; 39(3):669-76. PubMed ID: 21852337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step investigation of lung cancer detection by sniffer dogs.
    Mazzola SM; Pirrone F; Sedda G; Gasparri R; Romano R; Spaggiari L; Mariangela A
    J Breath Res; 2020 Mar; 14(2):026011. PubMed ID: 31995790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the art: canine olfaction used for cancer detection on the basis of breath odour. Perspectives and limitations.
    Jezierski T; Walczak M; Ligor T; Rudnicka J; Buszewski B
    J Breath Res; 2015 May; 9(2):027001. PubMed ID: 25944810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
    Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An odour of disease and decay: the nose as a diagnostic instrument].
    Bomers MK; Smulders YM
    Ned Tijdschr Geneeskd; 2015; 159():A9434. PubMed ID: 26606582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer.
    Matsumura K; Opiekun M; Oka H; Vachani A; Albelda SM; Yamazaki K; Beauchamp GK
    PLoS One; 2010 Jan; 5(1):e8819. PubMed ID: 20111698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Please puff once! Is it possible to diagnose cancer by smell?].
    Schipper J
    MMW Fortschr Med; 2009 Dec; 151(49-50):6. PubMed ID: 20085067
    [No Abstract]   [Full Text] [Related]  

  • 12. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
    Biehl W; Hattesohl A; Jörres RA; Duell T; Althöhn U; Koczulla AR; Schmetzer H
    Acta Oncol; 2019 Sep; 58(9):1216-1224. PubMed ID: 31311375
    [No Abstract]   [Full Text] [Related]  

  • 14. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Illicit Drugs by Trained Honeybees (Apis mellifera).
    Schott M; Klein B; Vilcinskas A
    PLoS One; 2015; 10(6):e0128528. PubMed ID: 26083377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoscopically obtained volatile biomarkers in lung cancer.
    Darwiche K; Baumbach JI; Sommerwerck U; Teschler H; Freitag L
    Lung; 2011 Dec; 189(6):445-52. PubMed ID: 21968685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volatile signature for the early diagnosis of lung cancer.
    Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
    J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Sensory Stimulation on Exhaled Volatile Organic Compounds.
    Mazzatenta A; Pokorski M; Di Tano A; Cacchio M; Di Giulio C
    Adv Exp Med Biol; 2016; 884():75-9. PubMed ID: 26453064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It Doesn't Smell Like Cancer to Me: The Promise of Exhaled Breath Biomarkers for Lung Cancer Diagnosis.
    Kammer MN; Paez R
    Chest; 2023 Mar; 163(3):479-480. PubMed ID: 36894259
    [No Abstract]   [Full Text] [Related]  

  • 20. Breath Testing for Barrett's Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device.
    Chan DK; Zakko L; Visrodia KH; Leggett CL; Lutzke LS; Clemens MA; Allen JD; Anderson MA; Wang KK
    Gastroenterology; 2017 Jan; 152(1):24-26. PubMed ID: 27825962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.